Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Rafael Holdings Inc

RFL ✗ NOT COMPLIANT ☆ Track — members

NYSE · Healthcare · Pharmaceuticals ·

USA Micro Cap Analyst: N/A

Last Close

$1.99

▲ +1.02%

Market Cap $103.48M · Vol 28.84K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$103.48M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

35.05

Momentum

Beta

0.36

vs Market

52W High

$3.94

49.49% below

52W Low

$1.13

76.11% above

Volume

28.84K

Avg 30.25K

P/B

0.94

Price-to-book

ROE

N/A

Return on equity

Free Float

61.77%

Public shares

Shariah Compliance8 STANDARDS

✗ Rafael Holdings Inc (RFL) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does RFL pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-2.93%

-17.08%

+51.91%

+65.83%

YTD

+68.64%

+23.60%

-9.07%

-95.92%

Financials & Valuation

TTM · Annual

Total Revenue	$917.00K
Net Income	$-30,643,000.00
Revenue Growth (YoY)	-50.55%
Gross Margin	53.98%
Operating Margin	-2,847.22%
Net Profit Margin	-3,341.66%
ROE	N/A
ROA · ROIC	-31.47% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	55.00
P/B	0.94
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	52.00M

Technical Indicators

50-Day SMA	$2.29
200-Day SMA	$1.53
RSI (14)	35.05
Beta	0.36
52-Week High	$3.94
52-Week Low	$1.13

Volume Today	28.84K
Avg Daily Volume (30D)	30.25K
Relative Volume	0.95x
Volatility (10D)	62.45
Volatility (30D)	90.69
Free Float	61.77%

Analyst Consensus

N/A

Current Price $1.99

Mean Target N/A

52W Low$1.13 52W High$3.94

Current

Target

$1.13 $3.94

Current Analyst target

· 0 analysts

Identifiers

ExchangeNYSE

FIGIBBG00J3YYSB9

ISINUS75062E1064

CountryUnited States of America

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

Rafael Holdings, Inc. is a biotechnology company that develops pharmaceuticals and holds interests in clinical and early-stage companies that develop pharmaceuticals and medical devices. The Company's segments include Healthcare, Infusion Technology and Real Estate. The Company’s lead candidate is Trappsol Cyclo, which is being evaluated in clinical trials for the potential treatment of Niemann-Pick Disease Type C1 (NPC1), a rare, fatal and progressive genetic disorder. The Healthcare segment comprises equity interests in LipoMedix Pharmaceuticals Ltd., Barer Institute Inc., Cornerstone Pharmaceuticals, Inc., Cyclo, and Rafael Medical Devices, LLC. The Real Estate segment consists of the Company’s real estate holdings, which comprise a portion of one commercial building in Israel. The Infusion Technology segment comprises equity interests in Day Three Labs, Inc. LipoMedix Pharmaceuticals Ltd. is a clinical-stage pharmaceutical company.